You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult acute promyelocytic leukemia (M3)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Chicago, Illinois
  • +2 more
Jan 12, 2023

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Acute Promyelocytic Leukemia Trial in United States (SY-2101, Arsenic Trioxide)

Recruiting
  • Acute Promyelocytic Leukemia
  • Birmingham, Alabama
  • +4 more
Jul 12, 2022

DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
  • +8 more
  • Laboratory Biomarker Analysis
  • Philadelphia, Pennsylvania
    Childrens Oncology Group
Jul 12, 2022

Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Vienna, Austria
  • +3 more
Jun 8, 2023

RWE of 1st Line Treatment With ATO/ATRA for Adult APL

Recruiting
  • Promyelocytic Leukemia, Adult Acute
  • Evaluation of first line treatment with ATO/ATRA outcome
  • Caba, Argentina
  • +1 more
Nov 9, 2021

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 2, 2023

Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)

Recruiting
  • Acute Myeloid Leukemia, Adult
  • cladribine + homoharringtonine + cytarabine
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of Med
Jun 13, 2023

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +15 more
  • trebananib
  • +3 more
  • Buffalo, New York
  • +1 more
Sep 8, 2022

Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,

Terminated
  • Adult Acute Basophilic Leukemia
  • +16 more
  • eltrombopag olamine
  • standard follow-up care
  • Atlanta, Georgia
  • +1 more
Jul 20, 2022

Leukemia Trial in Austria, Germany, Italy (arsenic trioxide, idarubicin, mercaptopurine)

Completed
  • Leukemia
  • arsenic trioxide
  • +5 more
  • Innsbruck, Austria
  • +109 more
Oct 10, 2022

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia Trial in Wuhan (T cell injection targeting FLT3 chimeric antigen

Recruiting
  • FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia
  • T cell injection targeting FLT3 chimeric antigen receptor
  • Wuhan, Hubei, China
    Union Hospital, affiliated with TongJi Medical College, HuaZhong
Jun 20, 2022

Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)

Recruiting
  • Acute Promyelocytic Leukemia
  • Realgar-Indigo naturalis formula
  • +3 more
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Aug 31, 2021

Leukemia Trial in Tianjin (DNR:, Ara-c)

Completed
Has Results
  • Leukemia
  • Tianjin, Tianjin, China
  • +1 more
Aug 8, 2021

Leukemia, Myeloid, Acute, MDS Trial in Japan, Korea, Republic of, Taiwan (Pevonedistat 25 mg/m^2, Pevonedistat 44 mg/m^2,

Completed
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • Pevonedistat 25 mg/m^2
  • +4 more
  • Maebashi City, Japan
  • +8 more
Jun 23, 2022

Survival in Adult MRD Positive Acute Lymphoblastic Leukemia

Completed
  • Acute Lymphoblastic Leukemia
    • Brno, Czechia
    • +9 more
    Sep 12, 2022

    Acute Myeloid Leukemia Trial (with or without venetoclax)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • with or without venetoclax
    • (no location specified)
    Apr 29, 2022

    AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

    Not yet recruiting
    • AML, Adult
    • +4 more
    • Amiens, France
    • +19 more
    Sep 1, 2023

    Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level

    Not yet recruiting
    • Relapsed Adult AML
    • Refractory AML
    • Navitoclax Dose Level -1
    • +10 more
    • Milwaukee, Wisconsin
      Froedtert Hospital & the Medical College of Wisconsin
    Aug 17, 2023

    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult

    Active, not recruiting
    Has Results
    • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
    • +18 more
    • eltrombopag olamine
    • Cleveland, Ohio
      Case Comprehensive Cancer Center
    Nov 29, 2021

    Acute Myeloid Leukemia (AML), Multiple Myeloma (MM) Trial (3x10(6) CART-38 cellls, 7x10(5) CART-38 cells, 7x10(6) CART-38 cells)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Multiple Myeloma (MM)
    • 3x10(6) CART-38 cellls
    • +5 more
    • (no location specified)
    Jul 15, 2022

    Leukemia, Acute Lymphocytic Trial in Durham (Copanlisib)

    Recruiting
    • Leukemia, Acute Lymphocytic
    • Durham, North Carolina
      Duke Cancer Center
    Jun 28, 2022

    Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,

    Recruiting
    • Acute Myeloid Leukemia in Remission
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 13, 2022

    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in United

    Completed
    Has Results
    • Adult Acute Basophilic Leukemia
    • +16 more
    • Little Rock, Arkansas
    • +53 more
    Jan 13, 2022